Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,144	2,357	1,588	3,178	1,001	475
Market Cap Growth	16.67%	48.44%	-50.04%	217.33%	110.87%	222.46%
Enterprise Value	1,848	2,057	1,374	3,092	970	457
Last Close Price	16.97	18.61	12.50	24.97	7.95	3.77
PE Ratio	72.93	77.43	11.18	20.23	5442.54	-
Forward PE	59.51	55.42	19.45	32.20	19.55	135.13
PS Ratio	33.16	36.46	7.32	13.70	64.96	148.54
PB Ratio	6.33	6.96	4.36	15.49	24.08	12.10
P/TBV Ratio	6.33	6.96	4.36	15.49	24.08	12.10
P/FCF Ratio	17.10	18.80	-	17.19	279.73	-
P/OCF Ratio	17.09	18.79	-	17.18	278.25	-
EV/Sales Ratio	28.58	31.82	6.34	13.33	62.94	142.84
EV/EBITDA Ratio	83.75	93.25	7.67	15.52	-	-
EV/EBIT Ratio	83.83	93.35	7.67	15.52	-	-
EV/FCF Ratio	14.74	16.41	-	16.73	271.04	-
Net Debt / Equity Ratio	-0.87	-0.87	-0.61	-1.11	-0.97	-0.94
Net Debt / EBITDA Ratio	-13.42	-13.42	-1.24	-1.15	55.65	4.47
Net Debt / FCF Ratio	-2.36	-2.36	19.70	-1.24	-11.22	3.69
Asset Turnover	0.17	0.17	0.66	1.59	0.37	0.10
Quick Ratio	74.40	74.40	8.69	5.68	24.59	47.58
Current Ratio	76.60	76.60	8.73	5.78	25.77	49.87
Return on Equity (ROE)	8.67%	8.67%	49.92%	127.30%	0.46%	-24.57%
Return on Assets (ROA)	3.66%	3.66%	34.05%	85.52%	-1.10%	-15.83%
Return on Invested Capital (ROIC)	40.70%	18.73%	235.12%	-	-37.74%	-663.42%
Return on Capital Employed (ROCE)	6.50%	6.50%	49.20%	97.10%	-1.80%	-21.00%
Earnings Yield	1.42%	1.29%	8.95%	4.94%	0.02%	-1.64%
FCF Yield	5.85%	5.32%	-0.71%	5.82%	0.36%	-2.10%
Buyback Yield / Dilution	0.01%	0.01%	-0.01%	-1.44%	-8.76%	-10.71%